Acanthosis nigricans: a practical approach to evaluation and management.
Publication
, Journal Article
Higgins, SP; Freemark, M; Prose, NS
Published in: Dermatol Online J
September 15, 2008
Acanthosis nigricans is a dermatosis characterized by thickened, hyperpigmented plaques, typically of the intertriginous surfaces and neck. Common in some populations, its prevalence depends on race. Clinicians should recognize acanthosis nigricans; it heralds disorders ranging from endocrinologic disturbances to malignancy. In this review, we discuss the pathogenesis of acanthosis nigricans and its clinical implications and management.
Duke Scholars
Published In
Dermatol Online J
EISSN
1087-2108
Publication Date
September 15, 2008
Volume
14
Issue
9
Start / End Page
2
Location
United States
Related Subject Headings
- Retinoids
- Receptor Protein-Tyrosine Kinases
- Prevalence
- Neoplasms
- Male
- Low-Level Light Therapy
- Insulin-Like Growth Factor I
- Insulin Resistance
- Hypoglycemic Agents
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Higgins, S. P., Freemark, M., & Prose, N. S. (2008). Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J, 14(9), 2.
Higgins, Steven P., Michael Freemark, and Neil S. Prose. “Acanthosis nigricans: a practical approach to evaluation and management.” Dermatol Online J 14, no. 9 (September 15, 2008): 2.
Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008 Sep 15;14(9):2.
Higgins, Steven P., et al. “Acanthosis nigricans: a practical approach to evaluation and management.” Dermatol Online J, vol. 14, no. 9, Sept. 2008, p. 2.
Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008 Sep 15;14(9):2.
Published In
Dermatol Online J
EISSN
1087-2108
Publication Date
September 15, 2008
Volume
14
Issue
9
Start / End Page
2
Location
United States
Related Subject Headings
- Retinoids
- Receptor Protein-Tyrosine Kinases
- Prevalence
- Neoplasms
- Male
- Low-Level Light Therapy
- Insulin-Like Growth Factor I
- Insulin Resistance
- Hypoglycemic Agents
- Humans